Gu SX - Search Results

1

Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS-CoV-2 M^pro inhibitors.

Peng JQ, Xiao YQ, Long J, Zhang SS, Zhu YY, Gu SX. Peng JQ, et al. Among authors: gu sx. Bioorg Med Chem Lett. 2024 Dec 1;114:130011. doi: 10.1016/j.bmcl.2024.130011. Epub 2024 Oct 30. Bioorg Med Chem Lett. 2024. PMID: 39486486

2

Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.

Gu SX, Xue P, Ju XL, Zhu YY. Gu SX, et al. Bioorg Med Chem. 2016 Nov 1;24(21):5007-5016. doi: 10.1016/j.bmc.2016.09.025. Epub 2016 Sep 12. Bioorg Med Chem. 2016. PMID: 27658796 Review.

3

Indole derivatives as tubulin polymerization inhibitors for the development of promising anticancer agents.

Hong Y, Zhu YY, He Q, Gu SX. Hong Y, et al. Among authors: gu sx. Bioorg Med Chem. 2022 Feb 1;55:116597. doi: 10.1016/j.bmc.2021.116597. Epub 2021 Dec 30. Bioorg Med Chem. 2022. PMID: 34995858 Review.

4

Hybrids of delavirdine and piperdin-4-yl-aminopyrimidines (DPAPYs) as potent HIV-1 NNRTIs: Design, synthesis and biological activities.

Ming W, Lu WL, Pannecouque C, Chen J, Wang HF, Xiao YQ, Hu S, Gu SX, Zhu YY, Chen FE. Ming W, et al. Among authors: gu sx. Eur J Med Chem. 2023 Feb 15;248:115114. doi: 10.1016/j.ejmech.2023.115114. Epub 2023 Jan 11. Eur J Med Chem. 2023. PMID: 36640458

5

Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review.

Xiao YQ, Long J, Zhang SS, Zhu YY, Gu SX. Xiao YQ, et al. Among authors: gu sx. Bioorg Chem. 2024 Jun;147:107380. doi: 10.1016/j.bioorg.2024.107380. Epub 2024 Apr 16. Bioorg Chem. 2024. PMID: 38636432 Review.

6

A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities.

Gu SX, Qiao H, Zhu YY, Shu QC, Liu H, Ju XL, De Clercq E, Balzarini J, Pannecouque C. Gu SX, et al. Bioorg Med Chem. 2015 Oct 15;23(20):6587-93. doi: 10.1016/j.bmc.2015.09.020. Epub 2015 Sep 11. Bioorg Med Chem. 2015. PMID: 26385446

7

Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.

Lu HH, Xue P, Zhu YY, Ju XL, Zheng XJ, Zhang X, Xiao T, Pannecouque C, Li TT, Gu SX. Lu HH, et al. Among authors: gu sx. Bioorg Med Chem. 2017 Apr 15;25(8):2491-2497. doi: 10.1016/j.bmc.2017.03.009. Epub 2017 Mar 6. Bioorg Med Chem. 2017. PMID: 28314514

8

Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.

Xue P, Lu HH, Zhu YY, Ju XL, Pannecouque C, Zheng XJ, Liu GY, Zhang XL, Gu SX. Xue P, et al. Among authors: gu sx. Bioorg Med Chem Lett. 2017 Apr 15;27(8):1640-1643. doi: 10.1016/j.bmcl.2017.03.009. Epub 2017 Mar 7. Bioorg Med Chem Lett. 2017. PMID: 28314598

9

Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.

Gu SX, Lu HH, Liu GY, Ju XL, Zhu YY. Gu SX, et al. Eur J Med Chem. 2018 Oct 5;158:371-392. doi: 10.1016/j.ejmech.2018.09.013. Epub 2018 Sep 6. Eur J Med Chem. 2018. PMID: 30223123 Review.

10

Recent progress in HIV-1 inhibitors targeting the entrance channel of HIV-1 non-nucleoside reverse transcriptase inhibitor binding pocket.

Gu SX, Xiao T, Zhu YY, Liu GY, Chen FE. Gu SX, et al. Eur J Med Chem. 2019 Jul 15;174:277-291. doi: 10.1016/j.ejmech.2019.04.054. Epub 2019 Apr 24. Eur J Med Chem. 2019. PMID: 31051402 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters